In Vitro Efficacy of Antivirals and Monoclonal Antibodies against SARS-CoV-2 Omicron Lineages XBB.1.9.1, XBB.1.9.3, XBB.1.5, XBB.1.16, XBB.2.4, BQ.1.1.45, CH.1.1, and CL.1

The spread of COVID-19 continues, expressed by periodic wave-like increases in morbidity and mortality. The reason for the periodic increases in morbidity is the emergence and spread of novel genetic variants of SARS-CoV-2. A decrease in the efficacy of monoclonal antibodies (mAbs) has been reported...

Descripción completa

Detalles Bibliográficos
Autores principales: Pochtovyi, Andrei A., Kustova, Daria D., Siniavin, Andrei E., Dolzhikova, Inna V., Shidlovskaya, Elena V., Shpakova, Olga G., Vasilchenko, Lyudmila A., Glavatskaya, Arina A., Kuznetsova, Nadezhda A., Iliukhina, Anna A., Shelkov, Artem Y., Grinkevich, Olesia M., Komarov, Andrei G., Logunov, Denis Y., Gushchin, Vladimir A., Gintsburg, Alexander L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611309/
https://www.ncbi.nlm.nih.gov/pubmed/37896937
http://dx.doi.org/10.3390/vaccines11101533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611309/
https://www.ncbi.nlm.nih.gov/pubmed/37896937
http://dx.doi.org/10.3390/vaccines11101533

Ejemplares similares